It will hover from 3.50-5.50 if we get no positive or negative news till next earnings.
SNTA management will re-issue more shares on the market which will dilute the stock even more. Management needs either a better presentation or better results the next time they do a presentation on their market anaysis for their products. It seems the Big Pharma's did not like what they saw.
Tough to blame this on the MarketMakers.
Still would like to know why Management would buy the stock at these levels. Maybe their is sometype of hope but the market is saying otherwise.